CORRECT and REPLACE Soleo Health Selected as Limited Drug Delivery Partner for LEQVIO® Delivery

FRISCO, Texas–(BUSINESS WIRE)–The title of the press release dated July 26, 2022 should read: Soleo Health Selected as Limited Drug Delivery Partner to Deliver LEQVIO®

The updated version reads as follows:

SOLEO HEALTH SELECTED AS LIMITED DRUG DISTRIBUTION PARTNER FOR LEQVIO® DELIVERY

The company will distribute a recent FDA-approved treatment to lower bad cholesterol

Soleo Healtha leading innovator and national provider of complex specialty pharmaceutical services, today announced that it has been selected as a limited distribution partner for cardiovascular drugs LEQVIO®made by Novartisa world leader in medicines.

LEQVIO (inclisiran) injection is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with clinical atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia (HeFH) who require further reduction of low-density lipoprotein cholesterol (LDL-C).

LEQVIO is a subcutaneous injection that Soleo Health will administer to patients at home or at one of the company’s ambulatory infusion centers (AICs) nationwide.

Along with administering LEQVIO, Soleo Health will leverage its proprietary clinical outcomes program, SoleMetrics®, to collect and produce valuable real-world data over time for patients prescribed LEQVIO. SoleMetrics will collect intelligent results from patients throughout their LEQVIO journey to deliver clinical and economic value to key stakeholders.

“Soleo Health’s expertise in caring for patients with complex diseases and our ability to offer services at home or at other sites of care creates additional value for pharmaceutical manufacturers. We continue to expand our limited distribution partnerships with many drug manufacturers because they appreciate our dedication to clinical excellence and high quality care,” said Drew Walk, CEO of Soleo Health.

About Soleo Health

Soleo Health is an innovative national provider of complex specialty pharmaceutical services delivered at home or at other sites of care. Soleo Santé’s interdisciplinary clinical team includes highly experienced pharmacists, registered nurses, reimbursement specialists and patient care ambassadors. The company optimizes patient access solutions and provides comprehensive services, leading to quantifiable clinical and economic value, resulting in positive patient experiences.

Soleo Health operates 21 pitches across the United States with national nursing coverage and pharmacy licensing in 50 states and is accredited by URAC, ACHC with Distinction in Rare Diseases and Orphan Drugs, and the Joint Commission.

Visit www.soleohealth.com or connect with Soleo Health at LinkedIn, Facebook and Twitter for more information.

Comments are closed.